EVAN THOMPSON: Open Payments
NPI 1033735063 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 6 companies in 2025. Trend: 2023 $110 · 2024 $49 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: AUSTEDO XR, CAPLYTA, FANAPT, ARISTADA, INVEGA SUSTENNA, Auvelity.
Industry payments across MT — which companies pay providers there.
